CLYM Latest Press Releases

-- November 25, 2025 --

Climb Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 7:00 AM

-- November 6, 2025 --

Climb Bio Reports Third Quarter 2025 Financial Results and Provides Business Updates Globe Newswire 7:01 AM

-- November 3, 2025 --

Climb Bio to Present at Upcoming Investor Conferences Globe Newswire 7:00 AM

-- October 21, 2025 --

Climb Bio Names Adam Villa as SVP, Technical Operations and Ashley Jones as SVP, People & Workforce Strategy Globe Newswire 7:00 AM

-- October 17, 2025 --

Climb Bio to Present Data at American Society of Nephrology (ASN) Kidney Week 2025 Globe Newswire 7:00 AM

-- October 1, 2025 --

Climb Bio Appoints Susan Altschuller, Ph.D., MBA as Chief Financial Officer Globe Newswire 7:00 AM

-- September 29, 2025 --

Climb Bio Announces CLYM116 Preclinical Data Highlighting Potential for Best-In-Class Therapeutic for IgAN Globe Newswire 7:00 AM

-- September 4, 2025 --

Climb Bio to Host Webcast Highlighting CLYM116 and the IgA Nephropathy (IgAN) Opportunity on September 29, 2025 Globe Newswire 7:00 AM

-- August 25, 2025 --

UPDATE - Climb Bio to Present at Upcoming September 2025 Investor Conferences Globe Newswire 2:41 PM

Climb Bio to Present at Upcoming September 2025 Investor Conferences Globe Newswire 7:00 AM

-- August 12, 2025 --

Climb Bio Reports Second Quarter 2025 Financial Results and Provides Business Updates Globe Newswire 7:00 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software